Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster... Show more
LAB is expected to report earnings to fall 38.89% to -5 cents per share on May 07
Q1'25
Est.
$-0.05
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.04
Q1'24
Missed
by $0.17
The last earnings report on February 26 showed earnings per share of -9 cents, missing the estimate of -7 cents. With 188.41K shares outstanding, the current market capitalization sits at 1.04B.